Frédéric Peyrade

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

Jan B. Vermorken, Fernando Rivera, Éva Remenár et al. · New England Journal of Medicine · 2008 · 3.7K citations · Full text

Medicine, Oncology, Pharmacology +16

Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study

Nicolas Penel, Binh Bui, Jacques‐Olivier Bay et al. · Journal of Clinical Oncology · 2008 · 693 citations · Full text

Medicine, Oncology, Pharmacology +10

Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Esma Saâda-Bouzid, Cécile Defaucheux, Andy Karabajakian et al. · Annals of Oncology · 2017 · 609 citations

Medicine, Oncology, Pharmacotherapy +16

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

Frédéric Peyrade, Fabrice Jardin, Catherine Thiéblemont et al. · The Lancet Oncology · 2011 · 545 citations

Medicine, Immunology, Oncology +15

Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study

Jean Louis Lefèbvre, Y. Pointreau, Frédéric Rolland et al. · Journal of Clinical Oncology · 2013 · 418 citations · Full text

Medicine, Oncology, Otolaryngology +16